Medscape | FDA Panel Endorses Miltefosine for Leishmaniasis Medscape VL, an infection of the liver, spleen, and bone marrow, affects about 0.5 million people, primarily in the Indian subcontinent and East Africa. It is fatal if untreated. Current treatments include intravenous or intramuscular antimonials or intravenous ... |
